Drugs Affecting Lipid Metabolism

Table of Contents

1. Altmetric Badge
   Book Overview
2. Altmetric Badge
   Chapter 1 Relationship of Cholesterol to DNA Synthesis in Normal and Cancerous Cells
3. Altmetric Badge
   Chapter 2 Turnover of HMG CoA Reductase is Influenced by Phosphorylation
4. Altmetric Badge
   Chapter 3 Regulation of ACAT
5. Altmetric Badge
   Chapter 4 Dietary and Pharmacological Control of Cholesterol 7α-Hydroxylase
6. Altmetric Badge
   Chapter 5 Recent Advances in Metabolic Pathways of Bile Acid Synthesis
7. Altmetric Badge
   Chapter 6 Bile Acid Sequestrants: Do They Have a Future?
8. Altmetric Badge
   Chapter 7 Transport of Cholesterol and Cholesterol Esters by HDL
9. Altmetric Badge
   Chapter 8 Role of HDL in the Metabolism of the Plasma Lipoproteins
10. Altmetric Badge
    Chapter 9 The Structure of ApoB-100: Structure-Function Studies
11. Altmetric Badge
    Chapter 10 A Genetic Marker in the Apolipoprotein AI/CIII Gene Complex Associated with Hypercholesterolaemia
12. Altmetric Badge
    Chapter 11 Cellular and Molecular Biology of Apolipoproteins: Receptor-Mediated Regulation of Cholesterol Metabolism
13. Altmetric Badge
    Chapter 12 APOA-I and APOA-II Metabolism and Coronary Artery Disease
14. Altmetric Badge
    Chapter 13 Hypocholesterolemic Drugs and Lipoprotein Metabolism
15. Altmetric Badge
    Chapter 14 Hypotriglyceridemic Drugs and Lipoprotein Catabolism
16. Altmetric Badge
    Chapter 15 Lipolysis and Lipoprotein Metabolism
17. Altmetric Badge
    Chapter 16 Regulation of Lipoprotein Lipase Activity: Its Role in Lipid-Lowering Therapies
18. Altmetric Badge
    Chapter 17 Lipolysis and Antilipolytic Drugs at Different Ages
19. Altmetric Badge
    Chapter 18 Fatty Acid-Binding Proteins of Various Tissues
20. Altmetric Badge
    Chapter 19 Interaction of Lipid-Lowering Drugs with Fatty Acid-Binding Proteins
21. Altmetric Badge
    Chapter 20 Animal Models for Hyperlipidemia-Induced Atherosclerosis
22. Altmetric Badge
    Chapter 21 Animal Species as Models of Spontaneous and Induced Hyperlipidemias: A Critical Appraisal
23. Altmetric Badge
    Chapter 22 Rabbit Models Hypo- or Hyperresponsive to Changes in Diet
24. Altmetric Badge
    Chapter 23 Plasma Lipoproteins and Cholesterol Metabolism in a Strain of Hyperlipemic Rats
25. Altmetric Badge
    Chapter 24 Spontaneous Hypertriglyceridemia in a Non-Obese Rat Model: The IVA-SIV Rat
26. Altmetric Badge
    Chapter 25 Considerations for Controlled Clinical Testing of Safety and Efficacy of New Hypolipidemic Drugs
27. Altmetric Badge
    Chapter 26 Desirable Lipoprotein Parameters in Early Drug Trials
28. Altmetric Badge
    Chapter 27 Metabolic Studies with Lovastatin in Patients with Primary Hypercholesteremia
29. Altmetric Badge
    Chapter 28 Reduction of Plasma Lipids and Lipoproteins by Dietary Fish Oils in Patients with Hypertriglyceridemia
30. Altmetric Badge
    Chapter 29 Effects of Monounsaturated Fatty Acids Versus Complex Carbohydrates on Serum Lipoprotein Subfractions and Apolipoproteins in Healthy Men and Women
31. Altmetric Badge
    Chapter 30 Changes of Eicosanoid Formation in Relation to Dietary Lipids and in Hyperlipaemia
32. Altmetric Badge
    Chapter 31 Effects of Omega-3 Polyunsaturated Fatty Acids on Human Leukocyte Function and Biochemistry
33. Altmetric Badge
    Chapter 32 Dietary and Biochemical Studies with Textured Soy Proteins
34. Altmetric Badge
    Chapter 33 Detection of Reactive Free Radicals in Livers of Ethanol-Fed Rats: Potentiating Effect of High Fat Diets
35. Altmetric Badge
    Chapter 34 The Role of the Antioxidant Tocopherol in Lipid and Lipoprotein Metabolism
36. Altmetric Badge
    Chapter 35 Newer Aspects of Fats and Lipid Metabolism
37. Altmetric Badge
    Chapter 36 Can We Retard Atherogenesis by Modifying High-Density Lipoprotein Metabolism?
38. Altmetric Badge
    Chapter 37 Effects of Lipid-Lowering Drugs on High Density Lipoprotein Structure and Metabolism
39. Altmetric Badge
    Chapter 38 Enzyme-Inducers and High-Density Lipoproteins
40. Altmetric Badge
    Chapter 39 Gonadal Steroids and Hormone Antagonists
41. Altmetric Badge
    Chapter 40 The Effects of Adrenoceptor and Adrenergic Blocking Drugs on Plasma Lipoproteins
42. Altmetric Badge
    Chapter 41 The Influence of Terpenes and Analogues on Parameters of Atherosclerosis
43. Altmetric Badge
    Chapter 42 Initial Stages of Reverse Transport of Cholesterol
44. Altmetric Badge
    Chapter 43 Lipolytic Enzymes and HDL: Influence of Drugs and Hormones
45. Altmetric Badge
    Chapter 44 Human Apolipoprotein A-I and A-II Metabolism
46. Altmetric Badge
    Chapter 45 Roles of LCAT and Lipid Transfer Protein in HDL Metabolism
47. Altmetric Badge
    Chapter 46 The Profile of an HMG-CoA Reductase Inhibitor, CS-514 (SQ 31,000)
48. Altmetric Badge
    Chapter 47 Induction of Hepatic Low-Density Lipoprotein Receptors in Heterozygous WHHL Rabbits Treated with CS-514 Alone or CS-514 in Combination with Cholestyramine
49. Altmetric Badge
    Chapter 48 The Clinical Pharmacology of SQ 31,000 (CS 514) in Healthy Subjects
50. Altmetric Badge
    Chapter 49 Long-Term Effects of CS-514 on Serum Lipoprotein Lipid and Apolipoprotein Levels in Patients with Familial Hypercholesterolemia
51. Altmetric Badge
    Chapter 50 Intensive Drug Treatment for Familial Hypercholesterolemia
52. Altmetric Badge
    Chapter 51 Effect of CS-514 on Hypercholesterolemic Patients
53. Altmetric Badge
    Chapter 52 Hyperlipoproteinemia and Therapy: Results of a Multicenter Trial with Bezafibrate, a New Lipid-Lowering Drug
54. Altmetric Badge
    Chapter 53 Lipoprotein Changes Induced by Bezafibrate — 200 mg t. i. d. — and by Bezafibrate in a Slow-Release Preparation — 400 mg Once a Day — in Patients with Primary Hyperlipoproteinaemia
55. Altmetric Badge
    Chapter 54 Modifications of Apoprotein, Lipoprotein Parameters and HDL 2 and HDL 3 Subfractions During Treatment with Bezafibrate Retard
56. Altmetric Badge
    Chapter 55 Effect of Bezafibrate Retard on Plasma Lipoproteins in Hypertriglyceridemic Patients With and Without Diabetes Mellitus
57. Altmetric Badge
    Chapter 56 Long-Term Experience of a Single Daily Dose of Bezafibrate Retard 400 in Hyperlipoproteinaemia of Types IIa, IIb, and IV
58. Altmetric Badge
    Chapter 57 Effects of Bezafibrate on Lipoprotein Metabolism in Cell Culture
59. Altmetric Badge
    Chapter 58 Efficacy and Tolerance of Fenofibrate: A Ten-Year Experience
60. Altmetric Badge
    Chapter 59 Mechanism of Action of Fenofibrate: New Data
61. Altmetric Badge
    Chapter 60 Species Differences in the Metabolic Disposition of Fenofibrate
62. Altmetric Badge
    Chapter 61 Pharmacokinetics of Lipanthyl in the Elderly
63. Altmetric Badge
    Chapter 62 Effect of Fenofibrate on Lipoprotein Particles Predictive of Coronary Atherosclerosis
64. Altmetric Badge
    Chapter 63 Tentative Biochemical Approach to Fenofibrate Efficacy in Tinnitus Aurium
65. Altmetric Badge
    Chapter 64 Clinical Effect of Lipanthyl on Tinnitus Aurium and Other Symptoms Related to Inner Ear Disorders
66. Altmetric Badge
    Chapter 65 Effect of Gemfibrozil Administration on Biliary Lipid Secretion: A Crossover Study with Clofibrate
67. Altmetric Badge
    Chapter 66 Plasma Lipids, Lipoproteins, and Apoproteins During Gemfibrozil Treatment in Primary Hyperlipidemias
68. Altmetric Badge
    Chapter 67 Effects of Gemfibrozil on Lipoproteins in Patients with Dyslipoproteinemia
69. Altmetric Badge
    Chapter 68 HDL Deficiency, Atherosclerosis, and Stimulation of HDL Synthesis: Role of Gemfibrozil
70. Altmetric Badge
    Chapter 69 Hemorheological Activity of Gemfibrozil in Primary Hyperlipidemias
71. Altmetric Badge
    Chapter 70 Evaluation of Hypolipidemic and Other Useful Pharmacological Properties of Various Nicotinic Acid Derivatives
72. Altmetric Badge
    Chapter 71 Pharmacokinetics and Metabolism of 2-Tert-Butyl-4-Cyclohexyl-Phenyl Nicotinate (L-44) in Rats
73. Altmetric Badge
    Chapter 72 Effects of Etofibrate on Risk Factors of Atherosclerosis
74. Altmetric Badge
    Chapter 73 Hyperaggregability of Platelets in Patients with Hyperlipoproteinemia Type IIb Under Treatment with Etofibrate Retard and Acetylsalicylic Acid
75. Altmetric Badge
    Chapter 74 Effect of Etofibrate on Platelet Function in Hyperlipidemic Patients
76. Altmetric Badge
    Chapter 75 Importance of Phospholipids in Cholesterol-Solubilizing Capacity of High-Density Lipoproteins
77. Altmetric Badge
    Chapter 76 Effects of Polyunsaturated Phospholipid on Cholesterol Efflux in Vitro and in Experimental Animals and Human Subjects
78. Altmetric Badge
    Chapter 77 Phospholipids in Human Atherosclerosis
79. Altmetric Badge
    Chapter 78 Effect of Polyunsaturated Phosphatidylcholine (PPC) on Plasma Lipoproteins in Patients with Type II Hyperlipoproteinemia
80. Altmetric Badge
    Chapter 79 Dietary Lecithin: Metabolism, Fate, and Effects on Metabolism of Lipids and Lipoproteins
81. Altmetric Badge
    Chapter 80 Effects of Pantethine on Lipid Metabolism in Isolated Rat Hepatocytes
82. Altmetric Badge
    Chapter 81 Effects of Pantethine on Experimental Atherosclerosis in Rabbits
83. Altmetric Badge
    Chapter 82 Modified LDL in Humans: Effect of Pantethine
84. Altmetric Badge
    Chapter 83 Changes in Platelet Membrane Lipid Composition Following Pantethine Administration
85. Altmetric Badge
    Chapter 84 Pantethine Treatment in Type III Hyperlipoproteinemia